美股異動丨禾賽盤前續漲超7% 全球最高線數激光雷達AT1440商用車首發
昨日收漲12.75%的禾賽(HSAI.US)今日美股盤前續漲7.26%,報14.04美元。消息面上,禾賽科技與自動駕駛卡車技術公司卡爾動力4月21日宣佈深化戰略合作,禾賽全球最高線數車規級量產激光雷達AT1440在卡爾動力全球首款未來運輸機器人上首發,並同步搭載在量產的卡爾動力L4級自動駕駛卡車編隊解決方案中,助力卡爾動力實現自動駕駛貨運大規模商業化落地。此次合作標誌着雙方在推動高階自動駕駛商業化落地進程中邁出關鍵一步。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.